Drug Discovery

The successful path from lead optimization to candidate selection is a complex, iterative process that requires an integrated, interdisciplinary approach. IITRI’s experienced team of toxicologists, analytical chemists, cancer biologists, infectious disease scientists, and molecular biologists will partner with sponsors to develop the appropriate strategy to advance lead candidates. We offer a range of services to evaluate the efficacy and early safety of lead candidates, including pharmacokinetic analysis and non-GLP acute toxicology testing.